UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial

Journal of clinical oncology, 2011-07, Vol.29 (20), p.2815-2820

2011

Volltextzugriff (PDF)

Detecting Disabilities in Older Patients With Cancer: Comparison Between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13

Journal of clinical oncology, 2010-04, Vol.28 (12), p.2046-2050

2010

Volltextzugriff (PDF)

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population

BMC cancer, 2012-05, Vol.12 (1), p.208-208, Article 208

2012

Volltextzugriff (PDF)

Adjuvant Chemotherapy in Completely Resected Gastric Cancer: A Randomized Phase III Trial Conducted by GOIRC

JNCI : Journal of the National Cancer Institute, 2008-03, Vol.100 (6), p.388-398

2008

Volltextzugriff (PDF)

Angiogenesis in Head and Neck Cancer: A Review of the Literature

Journal of Oncology, 2012-01, Vol.2012 (2012), p.392-400-137

2012

Volltextzugriff (PDF)

Biomolecular Markers in Cancer of the Tongue

Journal of Oncology, 2009-01, Vol.2009 (2009), p.371-381

2009

Volltextzugriff (PDF)

Reply to M.J. Molina-Garrido et al

Journal of clinical oncology, 2011-08, Vol.29 (23), p.3202-3203

2011

Volltextzugriff (PDF)

miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo

Clinical science (1979), 2014-08, Vol.127 (4), p.233-242

2014

Volltextzugriff (PDF)

Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity

Anti-cancer drugs, 2006-03, Vol.17 (3), p.359-361

2006

Volltextzugriff (PDF)

Water reuse: >90% water yield in MBR/RO through concentrate recycling and CO₂ addition as scaling control

Water research (Oxford), 2011-11, Vol.45 (18), p.6141-6151

2011

Volltextzugriff (PDF)

Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)

Journal of geriatric oncology, 2015-07, Vol.6 (4), p.272-279

2015

Volltextzugriff (PDF)

Eribulin (E) and capecitabine (C), a combined treatment schedule in elderly metastatic breast cancer (EMBC): Efficacy and safety evaluation (E&S)

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.e20513-e20513

2014

Volltextzugriff (PDF)

Targeted therapies: cui prodest?

Journal of clinical oncology, 2007-10, Vol.25 (29), p.4691-4692

2007

Volltextzugriff (PDF)

Reply to C. Falci et al

Journal of clinical oncology, 2010-11, Vol.28 (32), p.e667-e667

2010

Volltextzugriff (PDF)

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

JNCI : Journal of the National Cancer Institute, 2003-03, Vol.95 (5), p.362-372

2003

Volltextzugriff (PDF)

The assessment of chemotherapy risk in elderly cancer patients: Validation of the CRASH score in an Italian cohort

Journal of clinical oncology, 2015-05, Vol.33 (15_suppl), p.e20521-e20521

2015

Volltextzugriff (PDF)

A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

The oncologist (Dayton, Ohio), 2013-04, Vol.18 (4), p.379-380

2013

Volltextzugriff (PDF)

Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydration

Anti-cancer drugs, 2016-02, Vol.27 (2), p.144-146

2016

Volltextzugriff (PDF)

Fatigue and functional dependence in older cancer patients

American journal of clinical oncology, 2008-10, Vol.31 (5), p.424-430

2008

Volltextzugriff (PDF)

Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome

Journal of clinical oncology, 2012-05, Vol.30 (15_suppl), p.e14676-e14676

2012

Volltextzugriff (PDF)

ONC-2012-001: A single-arm phase II study of tivantinib (ARQ 197) plus cetuximab in EGFR inhibitor-resistant MET high patients (pts) with locally advanced or metastatic colorectal cancer (CRC) with wild-type KRAS

Journal of clinical oncology, 2014-05, Vol.32 (15_suppl), p.TPS3661-TPS3661

2014

Volltextzugriff (PDF)

Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

JNCI : Journal of the National Cancer Institute, 2007-04, Vol.99 (8), p.601-607

2007

Volltextzugriff (PDF)

1 – 25 von 228

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(221)
Mit Volltextzugriff
(202)

Publikationsform

Artikel
(223)
Berichte
(3)
Reviews
(1)
Texte
(1)

Sprache

Englisch
(225)
Italienisch
(3)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(130)
Science & Technology
(130)
Humans
(113)
Female
(72)
Male
(71)
Hematology
(70)
Middle Aged
(59)
Adult
(53)
Oncology
(52)
Aged
(47)
Biological And Medical Sciences
(38)
Medical Sciences
(36)
Chronic Lymphocytic Leukemia
(25)
Prognosis
(25)
Adolescent
(21)
Aged, 80 And Over
(18)
Treatment Outcome
(18)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(17)
Leukemia
(16)
Survival Analysis
(16)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Cisplatin and fluorouracil with or without panitumumab in patients with recurrent or metastatic squamous-cell carcinoma of the head and neck (SPECTRUM): an open-label phase 3 randomised trial

Palifermin Decreases Severe Oral Mucositis of Patients Undergoing Postoperative Radiochemotherapy for Head and Neck Cancer: A Randomized, Placebo-Controlled Trial

Detecting Disabilities in Older Patients With Cancer: Comparison Between Comprehensive Geriatric Assessment and Vulnerable Elders Survey-13

Role of plasma EBV DNA levels in predicting recurrence of nasopharyngeal carcinoma in a Western population

Adjuvant Chemotherapy in Completely Resected Gastric Cancer: A Randomized Phase III Trial Conducted by GOIRC

Angiogenesis in Head and Neck Cancer: A Review of the Literature

Biomolecular Markers in Cancer of the Tongue

Erlotinib versus docetaxel as second-line treatment of patients with advanced non-small-cell lung cancer and wild-type EGFR tumours (TAILOR): a randomised controlled trial

Reply to M.J. Molina-Garrido et al

miR-296/Scribble axis is deregulated in human breast cancer and miR-296 restoration reduces tumour growth in vivo

Gemcitabine and atrial fibrillation: a rare manifestation of chemotherapy toxicity

Water reuse: >90% water yield in MBR/RO through concentrate recycling and CO₂ addition as scaling control

Pretreatment Quality of Life and Functional Status Assessment Significantly Predict Survival of Elderly Patients With Advanced Non—Small-Cell Lung Cancer Receiving Chemotherapy: A Prognostic Analysis of the Multicenter Italian Lung Cancer in the Elderly Study

Estimating the risk of chemotherapy toxicity in older patients with cancer: The role of the Vulnerable Elders Survey-13 (VES-13)

Eribulin (E) and capecitabine (C), a combined treatment schedule in elderly metastatic breast cancer (EMBC): Efficacy and safety evaluation (E&S)

Targeted therapies: cui prodest?

Reply to C. Falci et al

Chemotherapy for Elderly Patients With Advanced Non-Small-Cell Lung Cancer: The Multicenter Italian Lung Cancer in the Elderly Study (MILES) Phase III Randomized Trial

The assessment of chemotherapy risk in elderly cancer patients: Validation of the CRASH score in an Italian cohort

A Phase II Randomized Dose Escalation Trial of Sorafenib in Patients With Advanced Hepatocellular Carcinoma

Anti-epidermal growth factor receptor skin toxicity: a matter of topical hydration

Fatigue and functional dependence in older cancer patients

Sorafenib (SFB) treated elderly patients (E) with hepatocellular carcinoma (HCC): Chromogranine A (CGA) plus vascular endothelial growth factor (VEGF) as predicting factors (PF) of treatment outcome

ONC-2012-001: A single-arm phase II study of tivantinib (ARQ 197) plus cetuximab in EGFR inhibitor-resistant MET high patients (pts) with locally advanced or metastatic colorectal cancer (CRC) with wild-type KRAS

Adjuvant Treatment of High-Risk, Radically Resected Gastric Cancer Patients With 5-Fluorouracil, Leucovorin, Cisplatin, and Epidoxorubicin in a Randomized Controlled Trial

Suchergebnisse filtern